HomeSKYE • NASDAQ
add
Skye Bioscience Inc
Previous close
$1.31
Day range
$1.31 - $1.38
Year range
$1.14 - $5.75
Market cap
42.00M USD
Avg Volume
401.41K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.26M | 166.96% |
Net income | -12.75M | -227.19% |
Net profit margin | — | — |
Earnings per share | -0.32 | -216.62% |
EBITDA | -13.09M | -166.90% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 35.31M | -47.62% |
Total assets | 41.32M | -49.32% |
Total liabilities | 8.49M | 48.08% |
Total equity | 32.84M | — |
Shares outstanding | 32.06M | — |
Price to book | 1.24 | — |
Return on assets | -70.94% | — |
Return on capital | -85.91% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -12.75M | -227.19% |
Cash from operations | -13.36M | -153.94% |
Cash from investing | 7.97M | 651.16% |
Cash from financing | 0.00 | — |
Net change in cash | -5.40M | 19.54% |
Free cash flow | -8.76M | -49.05% |
About
Founded
2011
Website
Employees
16
